Remembrane
We focus on membrane lipidomics of in-vitro cultures and we develop customized in-vitro lipid supplementation in order to address major culturing issues or boost specific bioprocesses.
Launch date
Employees
Company register number BO0488880
Imola Emilia-Romagna (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | <1m | <1m |
| % growth | 451 % | 103 % | 13 % | (86 %) | (65 %) | 175 % | - |
| EBITDA | (<1m) | (<1m) | <1m | (<1m) | (<1m) | (<1m) | - |
| % EBITDA margin | (63 %) | (3 %) | 47 % | (270 %) | (387 %) | (7162 %) | - |
| Profit | (<1m) | (<1m) | <1m | (<1m) | (<1m) | (<1m) | - |
| % profit margin | (102 %) | (15 %) | 26 % | (229 %) | (406 %) | (8000 %) | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€50.0k | Grant | ||
| Total Funding | $55.0k | ||
Related Content
Recent News about Remembrane
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.